Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001753926-25-001079
Filing Date
2025-07-03
Accepted
2025-07-03 21:05:54
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 16748
  Complete submission text file 0001753926-25-001079.txt   18362
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005
Business Address
Friedberg Ezra M (Reporting) CIK: 0001679440 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41964 | Film No.: 251106840

Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Pelthos Therapeutics Inc. (Issuer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)